Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Characterisation of Human CD83 Expression on Immune Cells and Their Targeting with CD83 Antibodies to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation

Blood (2015) 126 (23): 3081.

https://doi.org/10.1182/blood.V126.23.3081.3081

Published: 2015

Journal Articles

Antibody Targeting of Activated Dendritic Cells Prevents AGVHD and Preserves T Cell Immunity.

Hannah Cullup, PhD, John Wilson, B.Sc(Hons), Alison M. Rice, Ph.D, Anne M. Dickinson, Ph.D., David J. Munster, Ph.D., Derek N.J. Hart, MBBS, D. Phil

Blood (2006) 108 (11): 3240.

https://doi.org/10.1182/blood.V108.11.3240.3240

Published: 2006

Journal Articles

Delayed Onset GVHD Following Reduced Intensity Conditioning HSCT Is Associated with Persisting Host DC and Late Emergence of Activated Donor DC.

Brie E. Turner, BSc (Hons), Melinda E. Kambouris, BSc(Hons), Janusz Lange, MD, Kerry Atkinson, MBBS, MD, Derek N. Hart, MBBS, DPhil, David J. Munster, PhD, Alison M. Rice, PhD

Blood (2006) 108 (11): 3218.

https://doi.org/10.1182/blood.V108.11.3218.3218

Published: 2006

Journal Articles

Conditioning Intensity and Dendritic Cell (DC) Activation: Implications for GVHD Control Using DC Depleting Antibodies.

Brie E. Turner, BSc (Hons), Melinda Christensen, B.Sc, Janusz Lange, MBBS, Ann-Marie Burns, Derek N.J. Hart, MBBS, D. Phil, Kerry Atkinson, MBBS, MD, David J. Munster, PhD, Alison M. Rice, PhD

Blood (2005) 106 (11): 3112.

https://doi.org/10.1182/blood.V106.11.3112.3112

Published: 2005

Journal Articles

Characterization of human blood dendritic cell subsets

Kelli P. A. MacDonald, David J. Munster, Georgina J. Clark, Andrzej Dzionek, Juergen Schmitz, Derek N. J. Hart

Blood (2002) 100 (13): 4512–4520.

https://doi.org/10.1182/blood-2001-11-0097

Published: 2002

NARROW

Characterisation of Human CD83 Expression on Immune Cells and Their Targeting with CD83 Antibodies to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation

Antibody Targeting of Activated Dendritic Cells Prevents AGVHD and Preserves T Cell Immunity.

Delayed Onset GVHD Following Reduced Intensity Conditioning HSCT Is Associated with Persisting Host DC and Late Emergence of Activated Donor DC.

Conditioning Intensity and Dendritic Cell (DC) Activation: Implications for GVHD Control Using DC Depleting Antibodies.

Characterization of human blood dendritic cell subsets

Email alerts

ASH Publications

American Society of Hematology

Characterisation of Human CD83 Expression on Immune Cells and Their Targeting with CD83 Antibodies to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation

Antibody Targeting of Activated Dendritic Cells Prevents AGVHD and Preserves T Cell Immunity.

Delayed Onset GVHD Following Reduced Intensity Conditioning HSCT Is Associated with Persisting Host DC and Late Emergence of Activated Donor DC.

Conditioning Intensity and Dendritic Cell (DC) Activation: Implications for GVHD Control Using DC Depleting Antibodies.

Characterization of human blood dendritic cell subsets

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only